Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
3.
Clin Otolaryngol ; 36(2): 121-8, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21414179

RESUMEN

OBJECTIVE: To investigate the necessity of routine application of hyperbaric oxygen therapy for sudden sensorineural hearing loss. DESIGN/SETTING AND PARTICIPANTS: A retrospective chart review looked at 465 patients, with 353 of them receiving pharmacologic treatments alone. Among these patients, 76 underwent systemic steroid treatment only (steroid group) and 277 received systemic steroids and dextran (steroid-dextran group). The remaining 112 patients were treated with hyperbaric oxygen in addition to pharmacologic agents (steroid-dextran-hyperbaric oxygen group). MAIN OUTCOME MEASURES: The outcome was determined by comparing the difference of pure-tone thresholds and absolute hearing gains after treatment calculated at each audiometric octave frequency or grouped frequencies of audiograms. On the basis of the severity of initial hearing loss, patients were classified at three scales of hearing impairments measured in decibels hearing level (dBHL): ≦ 70 dBHL, less severe; 71-90 dBHL, severe; and ≧ 91 dBHL, profound. The outcomes of their hearing recovery were classified into three recovery grades: good, fair and poor. RESULTS: In those patients with initial hearing loss >90 dBHL, the addition of hyperbaric oxygen to steroid-dextran gave a significant hearing gain difference (P = 0.030) by showing a greater hearing gain of 24.5 ± 2.7 dB compared with steroid only (12.9 ± 3.7 dB) or steroid-dextran (15.6 ± 2.7 dB). This outcome was confirmed when we compared the outcome using the recovery grading; steroid-dextran-hyperbaric oxygen group showed that more patients with initial profound (≧ 91 dBHL) hearing loss responded to hyperbaric oxygen treatment by exhibiting good and fair recoveries (2% and 70%) as compared with steroid only (0% and 42%) or steroid-dextran (8% and 46%) groups (P = 0.043), while the patients with initial severe (71-90 dBHL) and less severe (≦ 70 dBHL) hearing loss responded to the addition of hyperbaric oxygen treatment with less favourable recoveries. Furthermore, the addition of dextran in steroid-dextran group showed no significant benefit compared with the steroid group (P = 0.435). CONCLUSIONS: When applied as an adjuvant to pharmacologic agents, hyperbaric oxygen benefits patients with initial profound sudden sensorineural hearing loss. Therefore, we recommend the routine application of hyperbaric oxygen in conjunction with pharmacologic agents for those patients. The addition of dextran to steroid has no benefit and cannot be recommended.


Asunto(s)
Antiinflamatorios/administración & dosificación , Audiometría de Tonos Puros , Betametasona/análogos & derivados , Dextranos/administración & dosificación , Pérdida Auditiva Súbita/rehabilitación , Hemodilución , Oxigenoterapia Hiperbárica , Sustitutos del Plasma , Prednisona/administración & dosificación , Administración Oral , Adulto , Umbral Auditivo/efectos de los fármacos , Betametasona/administración & dosificación , Terapia Combinada , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Estudios de Seguimiento , Pérdida Auditiva Súbita/diagnóstico , Pérdida Auditiva Súbita/etiología , Humanos , Infusiones Intravenosas , Persona de Mediana Edad , Evaluación de Procesos y Resultados en Atención de Salud , Estudios Retrospectivos , Factores de Riesgo , Adulto Joven
4.
Forsch Komplementmed ; 17(3): 147-8, 2010.
Artículo en Alemán | MEDLINE | ID: mdl-20616519

RESUMEN

Tinnitus is one of the 20 most common reasons why patients aged 45-64 years consult a general practitioner in Germany. In the literature a correlation is claimed between disease patterns of the cervical spinal column and nuclei of cerebral nerves. In the case report presented here, a 30-year-old female patient with acute tinnitus after acute hearing loss was cured from her tinnitus after a single manual medical treatment at C0/C1, which supports the correlation claimed. If cervical spine diseases should therefore regularly be included in the differential diagnoses of acute tinnitus is a matter of further research.


Asunto(s)
Vértebras Cervicales , Pérdida Auditiva Súbita/rehabilitación , Manipulaciones Musculoesqueléticas/métodos , Acúfeno/rehabilitación , Adulto , Audiometría de Tonos Puros , Terapia Combinada , Femenino , Depuradores de Radicales Libres/administración & dosificación , Pérdida Auditiva Súbita/fisiopatología , Humanos , Derivados de Hidroxietil Almidón/administración & dosificación , Infusiones Intravenosas , Pentoxifilina , Sustitutos del Plasma , Acúfeno/etiología , Acúfeno/fisiopatología , Núcleos del Trigémino/fisiopatología
6.
Laryngorhinootologie ; 76(7): 395-7, 1997 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-9333289

RESUMEN

BACKGROUND: One of the main factors of sudden hearing impairment, acute vestibular disturbance, and acute tinnitus is generally thought to be an acute labyrinthine ischemia of varying degrees. However, the scientific basis for this assumption has not yet been proven, and there is a great variety of treatment modalities. Recent circulation research and fundamental physiological considerations led to the development of a new concept of treatment of these diseases. METHODS: In order to enhance the labyrinthine blood circulation, physiological and physical methods were tested in 42 patients, especially with regard to patient compliance and in addition to conventional therapy. The methods tested included active circulation training. Finnish bath observing certain precautions, sequentially increased temperature bathing, massage, and fango therapy of the neck. RESULTS: The compliance of the patients to the new concept was good, in some cases even enthusiastic, either to the "total body" methods or to the local neck treatment. CONCLUSION: The principle of active and/ or passive stimulation of blood circulation in acute labyrinthine ischemia has been well accepted by all patients. A study including functional results is in preparation.


Asunto(s)
Oído Interno/irrigación sanguínea , Pérdida Auditiva Súbita/rehabilitación , Isquemia/rehabilitación , Modalidades de Fisioterapia/métodos , Balneología , Pérdida Auditiva Súbita/etiología , Salud Holística , Humanos , Isquemia/etiología , Flujo Sanguíneo Regional/fisiología , Acúfeno/etiología , Acúfeno/rehabilitación
7.
HNO ; 42(10): 604-13, 1994 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-8002367

RESUMEN

Existing investigations of cervical hearing disorders have been carried out predominantly in patients in whom those with vertebrobasilar insufficiencies (VBI) could not be distinguished from patients suffering from functional deficit of the upper cervical spine. Since two different syndromes exist, no statement can be made about cervical hearing disorders. That deafness can occur in VBI is uncontested. In contrast, there remains a dispute whether a "vertebragenic hearing disorder" exists. This latter disorder is believed accompanied by tinnitus, a feeling of ear pressure, otalgia and deafness as symptoms of a functional deficit of the upper cervical spine. In reviewing the medical findings of 259 patients with well-defined functional deficits of the upper cervical spine and symptoms of cervical vertigo, subjective hearing disorders occurred in 15%. Audiometric threshold shifts of 5-25 dB, most often in lower frequencies, were observed in 40%. Additionally, results of click-evoked otoacoustic emissions (OAE) were negative in spite of approximately normal hearing. Findings in 62 patients suffering from vertebragenic hearing disorders are reported before and after chiropractic management. Results indicate that these hearing disorders are reversible, as demonstrated by audiometry and OAE. The therapy of choice is chiropractic manipulation of the upper cervical spine. The commoness of vertebragenic hearing disorders emphasizes their clinical and forensic importance.


Asunto(s)
Vértebras Cervicales , Pérdida Auditiva Sensorineural/etiología , Pérdida Auditiva Súbita/etiología , Enfermedades de la Columna Vertebral/complicaciones , Pruebas de Impedancia Acústica , Adulto , Audiometría de Respuesta Evocada , Umbral Auditivo/fisiología , Tronco Encefálico/fisiopatología , Vértebras Cervicales/fisiopatología , Quiropráctica , Potenciales Evocados Auditivos del Tronco Encefálico/fisiología , Femenino , Estudios de Seguimiento , Pérdida Auditiva Sensorineural/fisiopatología , Pérdida Auditiva Sensorineural/rehabilitación , Pérdida Auditiva Súbita/fisiopatología , Pérdida Auditiva Súbita/rehabilitación , Humanos , Masculino , Enfermedad de Meniere/etiología , Enfermedad de Meniere/fisiopatología , Enfermedad de Meniere/rehabilitación , Emisiones Otoacústicas Espontáneas/fisiología , Percepción de la Altura Tonal/fisiología , Reflejo Acústico/fisiología , Estudios Retrospectivos , Enfermedades de la Columna Vertebral/fisiopatología , Enfermedades de la Columna Vertebral/rehabilitación
8.
Acta Otolaryngol ; 88(5-6): 335-42, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-532608

RESUMEN

Ninety-one patients suffering from idiopathic sudden hearing loss are presented. Twenty-two patients were given medical treatment (vasodilators, steroid hormones and vitamins) alone (group 1). Forty-nine patients were treated with stellate ganglion block (SGB) plus oxygen hyperbaric therapy (OHP) (group 2) and 20 patients were treated with SGB plus OHP along with medical treatment (group 3). The SGB plus OHP treated patients were given bupivacaine, which induced Moor's anterior approach of SGB and then exposed to oxygen at a pressure of 2.4 ATA for 90 min. In group 1, 69% of the patients treated within one week after onset exhibited over 10 dB pure tone average improvement, with only 33% patients treated one to two weeks after onset experiencing over 10 dB. However, 74% of the patients in group 2 and 100% of the patients in group 3 who were treated within two weeks after onset exhibited over 10 dB improvement. More significantly, of the patients which experienced complete loss of hearing, 83% in group 2 and 100% in group 3, exhibited over 10 dB improvement, compared to only 33% in group 1. Moreover, 8 (40%) patients in group 3 recovered to within 20 dB of their normal hearing levels. In group 2, 17 patients were treated two to six weeks after onset and 12 (71%) patients had over 10 dB improvement. SGB plus OHP therapy was shown effective in the treatment of sudden idiopathic hearing loss even when patients were treated more than two weeks after onset.


Asunto(s)
Bloqueo Nervioso Autónomo , Pérdida Auditiva Súbita/terapia , Oxigenoterapia Hiperbárica , Adulto , Factores de Edad , Audiometría de Tonos Puros , Bupivacaína/uso terapéutico , Femenino , Pérdida Auditiva Súbita/rehabilitación , Humanos , Masculino , Ganglio Estrellado , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA